{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:17:28Z","timestamp":1789593448837,"version":"build-2803163510"},"reference-count":38,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,10,1]]},"DOI":"10.5551\/jat.64007","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T22:11:09Z","timestamp":1672265469000},"page":"1327-1335","source":"Crossref","is-referenced-by-count":9,"title":["Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease"],"prefix":"10.5551","volume":"30","author":[{"given":"Mitsuyoshi","family":"Takahara","sequence":"first","affiliation":[{"name":"Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kishiwada Tokushukai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Kansai Rosai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizo","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Morinomiya Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Rother J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I and Group ESCSD: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D and Walsh ME: 2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2017; 135: e726-e779","DOI":"10.1161\/CIR.0000000000000471"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Iida O, Takahara M and Mano T: Evidence-Experience Gap and Future Perspective on the Treatment of Peripheral Artery Disease. J Atheroscler Thromb, 2021; 28: 1251-1259","DOI":"10.5551\/jat.RV17058"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kawasaki D, Nakata A, Nishian K, Nishimura M, Fujiwara R, Nakata T and Fukunaga M: Impact of Peak Systolic Velocity Ratio after Drug-Coated Balloon for Femoropopliteal Disease: Three-Month Serial Observation Vessel Echo Study. J Atheroscler Thromb, 2022; 29: 1352-1358","DOI":"10.5551\/jat.63197"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Soga Y, Takahara M, Iida O, Suzuki K, Mori S, Kawasaki D, Haraguchi K, Yamaoka T and Ando K: Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease. J Atheroscler Thromb, 2022; 29: 1448-1457","DOI":"10.5551\/jat.63225"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J and Minar E: Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006; 354: 1879-1888","DOI":"10.1056\/NEJMoa051303"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Krankenberg H, Schl\u00fcter M, Steinkamp HJ, B\u00fcrgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tubler T and Zeller T: Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation, 2007; 116: 285-292","DOI":"10.1161\/CIRCULATIONAHA.107.689141"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gray WA, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Bachinsky W, Rivera E, Tauth J, Patarca R, Massaro J, Stoll HP, Jaff MR and Investigators SS: S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes. J Vasc Interv Radiol, 2015; 26: 21-28","DOI":"10.1016\/j.jvir.2014.09.018"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Chang IS, Chee HK, Park SW, Yun IJ, Hwang JJ, Lee SA, Kim JS, Chang SH and Jung HG: The primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patients. Korean J Radiol, 2011; 12: 203-209","DOI":"10.3348\/kjr.2011.12.2.203"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cui C, Huang X, Liu X, Li W, Lu X, Lu M, Jiang M and Yin M: Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings. J Vasc Surg, 2017; 65: 82-90","DOI":"10.1016\/j.jvs.2016.05.087"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Diehm N, Shang A, Silvestro A, Do DD, Dick F, Schmidli J, Mahler F and Baumgartner I: Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur J Vasc Endovasc Surg, 2006; 31: 59-63","DOI":"10.1016\/j.ejvs.2005.09.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wasmuth S, Baumgartner I, Do DD, Willenberg T, Saguner A, Zwahlen M and Diehm N: Renal insufficiency is independently associated with a distal distribution pattern of symptomatic lower-limb atherosclerosis. Eur J Vasc Endovasc Surg, 2010; 39: 591-596","DOI":"10.1016\/j.ejvs.2009.11.034"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takahara M, Iida O, Kohsaka S, Soga Y, Fujihara M, Shinke T, Amano T, Ikari Y, J EVT and investigators JP: Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases. Cardiovasc Diabetol, 2019; 18: 155","DOI":"10.1186\/s12933-019-0955-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tsujimura T, Takahara M, Iida O, Kohsaka S, Soga Y, Fujihara M, Mano T, Ohya M, Shinke T, Amano T and Ikari Y: In-Hospital Outcomes after Endovascular Therapy for Acute Limb Ischemia: A Report from a Japanese Nationwide Registry [J-EVT Registry]. J Atheroscler Thromb, 2021; 28: 1145-1152","DOI":"10.5551\/jat.60053"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Davaine JM, Querat J, Guyomarch B, Brennan M\u00c1, Costargent A, Chaillou P, Patra P and Goueffic Y: Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. Eur J Vasc Endovasc Surg, 2013; 46: 201-212","DOI":"10.1016\/j.ejvs.2013.05.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H and Hirawa N: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res, 2019; 42: 1235-1481","DOI":"10.1038\/s41440-019-0284-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Committee for E and Clinical Management of A: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984","DOI":"10.5551\/jat.GL2017"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K and Yoshioka N: Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int, 2020; 11: 165-223","DOI":"10.1007\/s13340-020-00439-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ouchi Y, Rakugi H, Arai H, Akishita M, Ito H, Toba K, Kai I and Joint Committee of Japan Gerontological Society (JGLS) and Japan Geriatrics Society (JGS) on the definition and classification of the elderly: Redefining the elderly as aged 75 years and older: Proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int, 2017; 17: 1045-1047","DOI":"10.1111\/ggi.13118"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Examination Committee of Criteria for \u2018Obesity Disease\u2019 in J and Japan Society for the Study of O: New criteria for \u2018obesity disease\u2019 in Japan. Circ J, 2002; 66: 987-992","DOI":"10.1253\/circj.66.987"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Takahara M, Iida O, Soga Y, Kodama A, Terashi H, Azuma N and investigators Ss: Current and Past Obesity in Japanese Patients with Critical Limb Ischemia Undergoing Revascularization. J Atheroscler Thromb, 2021; 28: 44-51","DOI":"10.5551\/jat.55145"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Henaut L, Mary A, Chillon JM, Kamel S and Massy ZA: The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function. Toxins (Basel), 2018; 10: 218","DOI":"10.3390\/toxins10060218"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Castillo-Rodriguez E, Pizarro-Sanchez S, Sanz AB, Ramos AM, Sanchez-Nino MD, Martin-Cleary C, Fernandez-Fernandez B and Ortiz A: Inflammatory Cytokines as Uremic Toxins: \u201cNi Son Todos Los Que Estan, Ni Estan Todos Los Que Son\u201d. Toxins (Basel), 2017; 9: 114","DOI":"10.3390\/toxins9040114"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS, Keating MT and Li DY: A critical role for elastin signaling in vascular morphogenesis and disease. Development, 2003; 130: 411-423","DOI":"10.1242\/dev.00223"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tai NR, Giudiceandrea A, Salacinski HJ, Seifalian AM and Hamilton G: In vivo femoropopliteal arterial wall compliance in subjects with and without lower limb vascular disease. J Vasc Surg, 1999; 30: 936-945","DOI":"10.1016\/S0741-5214(99)70020-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Takahara M, Soga Y, Fujihara M, Kawasaki D, Kozuki A and Iida O: Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication. J Atheroscler Thromb, 2022; 29: 474-481","DOI":"10.5551\/jat.62356"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yanaka K, Akahori H, Imanaka T, Miki K, Yoshihara N, Kimura T, Tanaka T, Asakura M and Ishihara M: Relationship Between Lipoprotein(a) and Angiographic Severity of Femoropopliteal Lesions. J Atheroscler Thromb, 2021; 28: 555-561","DOI":"10.5551\/jat.56457"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tomoi Y, Takahara M, Soga Y, Fujihara M, Iida O, Kawasaki D, Kozuki A and Ando K: Prognostic Value of the CHA2DS2-VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions. J Atheroscler Thromb, 2021; 28: 1153-1160","DOI":"10.5551\/jat.60772"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Tsubakimoto Y: New Risk Stratification in Patients with Femoropopliteal PAD. Can We Fight Against the Poor Prognosis? J Atheroscler Thromb, 2021; 28: 1128-1129","DOI":"10.5551\/jat.ED168"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Higashino N, Iida O, Hata Y, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Matsuda Y, Takahara M and Mano T: Impact of Longer Hemodialysis Vintage with Higher Serum Phosphorus Level on Clinical Outcomes in Patients with Chronic Limb-Threatening Ischemia Presenting Tissue Loss after Endovascular Therapy. J Atheroscler Thromb, 2022; 29: 370-378","DOI":"10.5551\/jat.60095"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Golledge J and Drovandi A: Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease. J Atheroscler Thromb, 2021; 28: 573-583","DOI":"10.5551\/jat.62778"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32) Hata Y, Iida O, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Higashino N, Toyoshima T, Kitano I, Tsuji Y, Takahara M and Mano T: Impact of Guideline-Directed Medical Therapy on 10-Year Mortality after Revascularization for Patients with Chronic Limb-Threatening Ischemia. J Atheroscler Thromb, 2022; doi: 10.5551\/jat.63773","DOI":"10.5551\/jat.63773"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33) Wu CK, Lin CH, Yar N, Kao ZK, Yang YB and Chen YY: Long-Term Effectiveness of Cilostazol in Patients with Hemodialysis with Peripheral Artery Disease. J Atheroscler Thromb, 2022; doi: 10.5551\/jat.63404","DOI":"10.5551\/jat.63404"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Matsumoto T, Yoshino S, Furuyama T, Morisaki K, Nakano K, Koga JI, Maehara Y, Komori K, Mori M and Egashira K: Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I\/IIa Clinical Trial. J Atheroscler Thromb, 2022; 29: 731-746","DOI":"10.5551\/jat.58941"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Takahara M, Iida O, Soga Y, Azuma N and Nanto S: Clinical Impact of Measures for Frailty Severity in Poor-Risk Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia. J Atheroscler Thromb, 2022; 29: 221-228","DOI":"10.5551\/jat.61481"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Kodama A, Takahara M, Iida O, Soga Y, Terashi H, Kawasaki D, Izumi Y, Mii S, Komori K and Azuma N: Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia. J Atheroscler Thromb, 2022; 29: 866-880","DOI":"10.5551\/jat.62892"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ban S, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y, Yamamoto K, Seguchi M, Wada H and Fujita H: Association of Asymptomatic Low Ankle-Brachial Index with Long-Term Clinical Outcomes in Patients after Acute Myocardial Infarction. J Atheroscler Thromb, 2022; 29: 992-1000","DOI":"10.5551\/jat.62998"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38) Fu X, Qi Y, Han P, Chen X, Jin F, Shen Z, Mou Y, Qi Z, Zhu J, Chen Y, Zhou W, Zheng Y, Zhang Z, Li M and Guo Q: Relationship Between Physical Performance and Peripheral Arterial Diseases in Different Age Groups of Chinese Community-Dwelling Older Adults. J Atheroscler Thromb, 2022; doi: 10.5551\/jat.63697","DOI":"10.5551\/jat.63697"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/10\/30_64007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T04:40:02Z","timestamp":1696653602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/10\/30_64007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64007","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,1]]},"article-number":"64007"}}